Dyslipidaemia plays a key role in the development of cardiovascular disease (CVD). Therefore, the identification and treatment of dyslipidaemia is important for both primary and secondary CVD prevention, and forms the basis of this article.
Financed by the National Centre for Research and Development under grant No. SP/I/1/77065/10 by the strategic scientific research and experimental development program:
SYNAT - “Interdisciplinary System for Interactive Scientific and Scientific-Technical Information”.